In Brief: Vybrique — Sildenafil Oral Film for Erectile Dysfunction
The FDA has approved Vybrique (IBSA), an oral film formulation of the phosphodiesterase type 5 (PDE5) inhibitor sildenafil, for treatment of erectile dysfunction (ED). Sildenafil oral tablets (Viagra, and generics) have been available since 1998. The manufacturer is promoting the new product as a "discreet, on-the-go" option that can be taken without water.
Publication Details
- Journal
- The medical letter on drugs and therapeutics/The medical letter
- Published
- 2026-05-11
- DOI
- https://doi.org/10.58347/tml.2026.1754e
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00